. Effect of an extract of Centella asiatica on the biodistribution of sodium pertechnetate (Na99mTcO4) and on the fixation of radioactivity on blood constituents. Brazilian Archives of Biology and Technology, 51 pp. 215-219.
INTRODUCTION
Centella asiatica (CA) has been used in Ayurveda (Indian system of medicine). This medicinal plant is known as Brahmi in India, belonging to Umbeliferas family and is native of tropical Asia, growing in wet places at an altitude up to 2000 m.
In South America, CA is easily found, particularly in the Southern region of Brazil. CA is a rasayan (general tonic), used in Ayurveda in preparations either with the whole plant, or with fresh leave extract for the treatment of skin disorders and as a moderator of the central nervous system. Parts of the plant contain triterpene saponins, asiatic acid and madecassic acid and triterpene derivatives (ester glucosyl asiaticoside and madecassoside) (Inamdar et al., 1996; Shobi et al., 2001 ). Taking into account their different applications, the CA extract has been tested with respect to its radioprotective properties against the effects of gamma radiation, mainly due to antioxidant properties of the extract (Sharma et al., 2002; Jayashree et al., 2003) . CA contains antioxidant molecules like carotenoids, ascorbic acid and terpenoids (Padma et al., 1998) . Antioxidants may scavenge the free radicals produced by ionizing radiation, thus protecting cells against free radical-induced cytotoxity and genotoxity (Goel et al., 1996) . Shobi et al. (2001) demonstrated that the administration of an aqueous extract of CA protects rats against the effects of gamma-rays, such as weight loss and damage to the gastrointestinal epithelium, which are also observed in cancer patients undergoing radiotherapy. Gamma-radiation emitting radionuclides are also utilized to label cellular and molecular structures and are used in nuclear medicine for medical imaging (single photon emission computed tomography -SPECT) (Saha, 2004 , BernardoFilho et al., 2005 . Sodium pertechnetate (Na 99m TcO 4 ), after intravenous administration, presents a preferential uptake by thyroid, stomach, intestinal tract and salivary glands (Owunwanne et al., 1995) . Red blood cells labeled with technetium-99m ( 99m Tc) are also employed in diagnostic procedures (Saha, 2004) . Drugs (natural and synthetic) could alter the biodistribution of radiopharmaceuticals and the labeling of blood constituents with 99m Tc (Bernardo-Filho et al., 2005; Fonseca et al., 2007 . This study evaluates biological effects of a CA extract on the biodistribution of the radiopharmaceutical Na 99m TcO 4 and on the fixation of the radioactivity on blood constituents.
MATERIALS AND METHODS
Experimental protocols followed in this study were approved by the Ethical Committee of the Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro (CEA/212/2007), Rio de Janeiro, RJ, Brazil.
For the preparation of the extract, 1g of CA was added to 10 mL of 0.9% NaCl solution and agitated in vortex for 1 minute. The preparation was centrifuged in a clinical centrifuge (2000 rpm, 15 minutes) and the supernatant was considered to be 100 mg/mL. To standardize the preparation of the extract, an absorbance spectrum (400 to 700 nm) of the extract was obtained in a spectrophotometer (Analyser, 800M, São Paulo, Brazil). An absorbance peak of 0.22±0.02 was obtained at 460 nm, and this was used as a marker of a quality control for the preparation of the extract and a mean of standardizing the concentrations of the extracts. For the biodistribution assay, male Wistar rats (3-4 months old, 250-350 g, n = 10) were treated with CA (6.25 mg/kg, oral via, 1 h) or with 0.9% NaCl, (saline solution) as control. After that, the animals were anesthetized with sodium thiopental (50 mg/kg) and sodium pertechnetate (0.3 mL, 3.7 MBq, 10 minutes) was administered into the orbital plexus. Animals were sacrificed, organs/tissues were withdrawn, weighed, the radioactivity was counted (Automatic Gamma Counter, Packard Instrument Co. Illinois, USA), and the percentage of radioactivity per gram of tissue/organ (% ATI/g) was determined.
For the radiolabeling assay, samples of heparinized blood were withdrawn by cardiac puncture from male Wistar rats (3-4 months, 250-350 g) treated with CA extract (6.25 mg/kg) or with 0.9% NaCl, as control. These samples were incubated with 99m Tc, as sodium pertechnetate (10 minutes). Blood samples were centrifuged and plasma (P) and blood cells (BC) were separated. Aliquots of P and BC were also precipitated by trichloroacetic acid (5%) and insoluble (IF) and soluble fractions were separated after centrifugation (1500 rpm, 5 minutes). Radioactivity was counted (Automatic Gamma Counter, Packard Instrument Co. Illinois, USA). The data are expressed as mean ± standard deviation of %ATI/g and %ATI. The values were analyzed by one-way variance analysis (ANOVA) with a p<0.05 as significant level followed by Bonferroni post-test. Statistical analysis was performed using InStat Graphpad software (GraphPad InStat version 3.00 for Windows 95, GraphPad Software, San Diego, California, USA).
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RESULTS
Our results demonstrate the effect CA extract had effect on the radioactivity uptake of various organs in the body, as well as on the fixation of the 99m Tc on the blood constituents with interesting findings. Table 1 represents the values obtained for the %ATI/g in animals treated with CA extracts. Data presented in this table indicate that the acute treatment with CA extract significantly (p<0.05) modify the %ATI/g of several organs/tissues, and in particular spleen, heart, duodenum, stomach, liver, muscle, kidney and testis. It is interesting to note that, the treatment with CA extract has generally resulted in reduced uptake of radiation in the various organs, with the exception of kidneys, where the %ATI/g has nearly tripled. Also, this extract, at the same conditions, was capable of altering the radiolabeling of blood constituents (Table 2 ). It has been described that extracts of medicinal plants could interfere with the biodistribution of sodium pertechnetate Rebello et al., 2008) . In those studies, alterations on the uptake of radiopharmaceutical were observed after repeated doses of extracts (about one week). Our data were obtained 1 hour after a unique treatment (acute treatment).
Interference on the fixation of the 99m Tc on the blood constituents was obtained after in vivo chronic treatment (four weeks) with an extract of eggplant (Capriles et al., 2002) . Similarly, our data suggest that CA extract would interfere on the radiolabeling of blood constituents in an acute treatment schedule. It is possible that substances in the extract, as well as its metabolites, would interact with the sodium pertechnetate or with structures in organ/tissues where these substance/metabolites had high uptake. For the this radiolabeling of blood constituents, substances in CA extract or their metabolites would interfere with the cell membrane or present redox action, altering the radiolabeling process. In fact, saponins have the ability to form complexes with steroids, proteins and phospholipids of membranes (Simões et al., 1999) Tc (lung perfusion or reticuloendotelial system). This may also be relevant in therapeutic applications against cancer using radiopharmaceuticals, where the radioactivty uptake in the various organs can be reduced, thus conferring radioprotection from radiation damage. In conclusion, our data indicate that acute treatment with Centella asiatica extracts could interfere with the biodistribution of sodium pertechnetate and the fixation of 99m Tc on blood constituents. 
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